Patent details

EP2227296 Title: COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2227296
WO Application Number:
US2009030291
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09701364.3
WO Publication Number:
WO2009089260
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
07/01/2009
Grant date:
25/11/2015
EP Publication Date:
15/09/2010
WO Publication Date:
16/07/2009
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/11/2015
EP B1 Publication Date:
25/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
06/01/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
25/11/2015
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
25/11/2015
 
 

 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, PRINCETON, NJ 08543, United States of America (US)

Inventor

Name:
JURE-KUNKEL, Maria
Address:
Princeton, NJ 08543, United States of America (US)

Priority

1

Priority Patent Number:
56957 P
Priority Date:
29/05/2008
Priority Country:
United States of America (US)

2

Priority Patent Number:
19778 P
Priority Date:
08/01/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/385; A61K 39/395; A61K 45/06; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
13/16
Publication date:
30/03/2016
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
48/15
Publication date:
25/11/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201548
Publication date:
25/11/2015
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/01/2016
Grace Period End Date:
31/07/2016
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Penalty Fee Amount:
140 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type